Predictors of Cervical Cancer Screening Among Infrequently Screened Women Completing Human Papillomavirus Self-Collection: My Body My Test-1
Overview
Authors
Affiliations
Approximately one-half of cervical cancer cases in the United States occur in underscreened or never-screened women. We examined predictors to completing Papanicolaou (Pap) testing and whether a positive human papillomavirus (HPV) self-collection result affects Pap testing adherence among underscreened women. Low-income women aged 30-65 years who reported no Pap testing in ≥4 years were recruited in North Carolina. Knowledge, attitudes, and barriers regarding cervical cancer and Pap testing were assessed by telephone questionnaires. We mailed self-collection kits for HPV testing and provided information regarding where to obtain affordable Pap testing. Participants received $45 for completing all activities. We used multivariable logistic regression to assess the predictors of longer reported time since last Pap (≥10 vs. 4-9 years) and of completion of Pap testing following study enrollment (follow-up Pap). Participants ( = 230) were primarily black (55%), uninsured (64%), and with ≤high school education (59%). Cost and finding an affordable clinic were the most commonly reported barriers to screening. White women and those with ≤high school education reported longer intervals since last Pap test. Half of the participants reported completing a follow-up Pap test (55%). Women with a positive HPV self-collection were five times more likely to report completing a follow-up Pap test than those with negative self-collection (odds ratio = 5.1, 95% confidence interval 1.4-25.7). Improving awareness of resources for affordable screening could increase cervical cancer screening in underserved women. Home-based HPV self-collection represents an opportunity to re-engage infrequently screened women into preventive screening services.
Al-Oseely S, Abdul Manaf R, Ismail S PLoS One. 2023; 18(12):e0290152.
PMID: 38100481 PMC: 10723656. DOI: 10.1371/journal.pone.0290152.
Social determinants of health and US cancer screening interventions: A systematic review.
Korn A, Walsh-Bailey C, Correa-Mendez M, DelNero P, Pilar M, Sandler B CA Cancer J Clin. 2023; 73(5):461-479.
PMID: 37329257 PMC: 10529377. DOI: 10.3322/caac.21801.
Pretsch P, Spees L, Brewer N, Hudgens M, Sanusi B, Rohner E Lancet Public Health. 2023; 8(6):e411-e421.
PMID: 37182529 PMC: 10283467. DOI: 10.1016/S2468-2667(23)00076-2.
Racial and Ethnic Disparities in Cervical Cancer Screening From Three U.S. Healthcare Settings.
Spencer J, Kim J, Tiro J, Feldman S, Kobrin S, Skinner C Am J Prev Med. 2023; 65(4):667-677.
PMID: 37146839 PMC: 11135625. DOI: 10.1016/j.amepre.2023.04.016.
Prevention Strategies and Early Diagnosis of Cervical Cancer: Current State and Prospects.
Kakotkin V, Semina E, Zadorkina T, Agapov M Diagnostics (Basel). 2023; 13(4).
PMID: 36832098 PMC: 9955852. DOI: 10.3390/diagnostics13040610.